Bryxta 300mg Injection: Effective Medication for Your Needs

Uses:

• Glioblastoma multiforme (brain cancer);
• Persistent, recurrent, or metastatic breast cancer;
• Metastatic cervical cancer;
• Advanced kidney cancer;
• Metastatic colorectal cancer;
• Advanced non-small-cell lung cancer;
• Liver cancer — hepatocellular carcinoma;
• Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer.

Therapeutic Effects:

• Bryxta 300mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers.
• It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), present in the lining of blood and lymph vessels in the body.
• It interrupts the interaction of VEGF-A with its receptors, inhibiting the formation of blood vessels that supply oxygen and nutrients to the tumor.
• As a result, it slows down the rate of progression of cancer.

Interaction with other drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications may interact with Bryxta 300mg Injection and cause undesirable side effects.

Safety Advices:

• Pregnancy: Inform your physician before starting treatment with Bryxta 300mg Injection in case you are pregnant or planning for pregnancy.
• Breastfeeding: Avoid breastfeeding for a minimum of 6 months after treatment with Bryxta 300mg Injection.
• Lungs: Inform your doctor if you have any lung conditions before starting treatment.
• Liver: Inform your physician before starting Bryxta 300mg Injection if you have liver diseases.
• Alcohol: Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Bryxta 300mg Injection.
• Driving: Avoid driving or using machinery while you are on treatment with Bryxta 300mg Injection as it is related to causing dizziness or sleepiness.

Side Effects:

• Serious: Headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing following surgery, protein in urine, severe infections, blood clots in arteries and blood vessels of lungs, gut perforation, nosebleeds and bleeding risk, heart problems with an increase in heart rate, mouth sores, dryness, shortness of breath.
• Common: Numbness in hands or feet, weakness and lack of energy, diarrhoea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, decrease in counts of white blood cells, fever, dry skin, back pain.

How to consume:

• Your physician or nurse will administer Bryxta 300mg Injection as an intravenous infusion.
• The infusion should be given immediately after the dilution.

FAQs:

• Q 1. Is Bryxta 300mg Injection used as standalone treatment in cancers? Bryxta 300mg Injection can be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.
• Q 2. Is it safe for women to use Bryxta 300mg Injection? While for women with reproductive potential subjected to Bryxta 300mg Injection, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment.
• Q 3. Is it safe to undergo a surgery during the treatment with Bryxta 300mg Injection? Bryxta 300mg Injection is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28 days before or after surgery.
• Q 4. Do the side effects of Bryxta 300mg Injection last for a chronic period? All the side effects that are relatively caused by Bryxta 300mg Injection occur until the drug concentration stays in the body.
• Q 5. How is Bryxta 300mg Injection administered? Bryxta 300mg Injection is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age.
• Q 6. Can I take Bryxta 300mg Injection if I am pregnant? Inform your physician before starting your treatment with Bryxta 300mg Injection in case you are pregnant or planning for pregnancy.

Fact Box:

• Molecule name: Bevacizumab;
• Therapeutic class: Anticancer;
• Pharmacological class: VEGF Inhibitor.

Tags: Bryxta, injection, 300mg, medical-drug, medication, pharmaceutical, healthcare, medicine, drug-product